Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline
References (21)
- et al.
Spectral and inhibitory interactions of (±)3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic ribosomes
Life Sci.
(1986) - et al.
Stereochemistry of the metabolism of MDMA to MDA
Life Sci.
(1989) - et al.
A preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine
Pharmacol. Biochem. Behav.
(1988) - et al.
Stimulus effects of N-monoethyl - 1 - (3,4-methylenedioxyphenyl) - 2 - aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH-MDA) in rats trained to discriminate MDMA from saline.
Pharmacol. Biochem. Behav.
(1989) - et al.
Structure-activity studies on methoxy-substituted phenylisopropylamines using drug discrimination methodology
Pharmacol. Biochem. Behav.
(1985) - et al.
Methcathinone: A new and potent amphetamine-like agent
Pharmacol. Biochem. Behav.
(1987) - et al.
The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats
Pharmacol. Biochem. Behav.
(1991) - et al.
Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats
Drug Alcohol Depend.
(1990) - et al.
Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: A pharmacokinetic analysis
Drug Metab. Disp.
(1990) Probit analysis
(1952)
Cited by (29)
In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation
2020, Drug and Alcohol DependenceCitation Excerpt :Fifteen minutes prior to an errorless training session, rats were injected with 0.9 % physiological saline (ip; S) or the training drug of 1.5 mg/kg MDMA (ip; D) and placed into a darkened chamber for a total of eight 20 min sessions in the following order: S, S, S, D, D, D, S, D. The 15 min pre-session injection interval and 1.5 mg/kg MDMA training dose were chosen from previous drug discrimination studies with MDMA in rats (Kueh and Baker, 2007; Glennon and Higgs, 1992; Schechter, 1987). The house light illuminated and the levers extended into the operant chamber after the 15 min period.
Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats
2012, Pharmacology Biochemistry and BehaviorCitation Excerpt :The current findings indicate that low MDMA doses (1.5, 3.0 mg/kg) have little to no effect on locomotor activity and fail to establish conditioned place preference in adult male Sprague–Dawley rats following three conditioning trials. Although locomotor activity during MDMA conditioning trials was not significantly different from activity levels following saline injections, it should be noted that MDMA is behaviorally active at these low doses in rodents as indicated by numerous reports that rats can be trained to discriminate them from vehicle (Glennon and Higgs, 1992; Baker et al., 1997; Fantegrossi et al., 2009). While MDMA alone failed to establish CPP, the concurrent administration of 20 mg/kg cocaine and 3.0 mg/kg MDMA showed a non significant trend towards establishing a CPP compared to either of these substances alone.
Neural and Cardiac Toxicities Associated With 3,4-Methylenedioxymethamphetamine (MDMA)
2009, International Review of NeurobiologyCitation Excerpt :Nash et al. (1988) showed that i.p. injections of 1–3 mg/kg of MDMA stimulate prolactin and corticosterone secretion in rats, and similar oral doses increase plasma prolactin and cortisol in human drug users (Harris et al., 2002; Mas et al., 1999). The dose of MDMA discriminated by rats and humans is identical: 1.5 mg/kg, i.p., for rats (Glennon and Higgs, 1992; Oberlender and Nichols, 1988; Schechter, 1988) and 1.5 mg/kg, p.o., for humans (Johanson et al., 2005). A few studies have shown that rats will self-administer MDMA at doses ranging from 0.25 to 1.0 mg/kg i.v., indicating these doses possess reinforcing efficacy (Ratzenboeck et al., 2001; Schenk et al., 2003).
Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges
2008, NeuroscienceCitation Excerpt :We sought to minimize this obstacle by designing an MDMA dosing regimen in rats based on threshold pharmacological doses. To this end, a typical dose of MDMA used for discrimination training in rats is 1.5 mg/kg i.p. (Schechter, 1988; Glennon and Higgs, 1992). Interestingly, human subjects discriminate this same dose administered orally in an experimental setting (Johanson et al., 2006), and recreational doses are in the range of 1–3 mg/kg (Cole et al., 2002; Schifano et al., 2006).
N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats
2007, Pharmacology Biochemistry and BehaviorCitation Excerpt :Comparative studies in humans have not been reported, but in drug discrimination studies using rats, MDMA and PMMA produce what appear to be similar discriminative stimulus effects. That is, stimulus generalization occurs between MDMA and PMMA regardless of which of the two is used as training drug (Glennon and Higgs, 1992; Glennon et al., 1997). Moreover, for both agents, the S(+)-optical isomer is the more potent, the α-methyl group can be homologated to an α-ethyl group with retention of action, and the preferred side chain conformation of both agents appears to be mimicked by an aminotetralin structure (Glennon et al., 1997; Young et al., 1999).